Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Difficult-to-Express Proteins Market?

There has been a significant increase in the size of the market for proteins that are difficult to express in recent years. It is projected to expand from $4.65 billion in 2024 to $5.22 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%. The growth observed in the historical period is due to factors such as an increased demand for protein therapeutics, challenges in drug development, advancements in biopharmaceuticals, limitations in technology, as well as gene editing and engineering.

What Growth Rate Is Forecasted for the Difficult-to-Express Proteins Market by 2029?

The market for difficult-to-express proteins is projected to experience a significant surge in the coming years. The market’s value is forecasted to reach $8.05 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.4%. This anticipated growth during the forecast period can be credited to advancements like the development of novel expression systems, emerging gene editing tools, improved cell-free systems, advanced protein engineering, and the incorporation of artificial intelligence and machine learning. Key trends observed for the forecast period are cutting-edge protein folding technologies, broader application of synthetic biology, specific protein modifications, advancements in biophysical characterization, and amplified use of CRISPR/CAS technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12602&type=smp

Which Key Companies Are Shaping the Future of the Difficult-to-Express Proteins Market?

Major companies operating in the difficult-to-express proteins market include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Bio-Techne Corp., GenScript Biotech Corporation, Ajinomoto Bio-Pharma Services, Novasep Holding SAS, Rentschler Biopharma SE, BioLegend Inc., Codexis Inc., Enzo Biochem Inc., Sino Biological Inc., Horizon Discovery Ltd., Creative Biolabs Inc., OriGene Technologies Inc., Celonic AG, Cube Biotech GmbH, Lucigen Corporation, Batavia Biosciences Inc., Cytovance Biologics Inc., Alloy Therapeutics Inc., Aragen Bioscience Inc., Selexis SA, LifeSensors Inc., Bionova Scientific Inc.

Which Factors Are Driving Demand in the Difficult-to-Express Proteins Industry?

The difficult-to-express protein market is anticipated to expand due to the increasing demand for recombinant proteins. These proteins, designed through altered DNA or recombinant DNA, facilitate the creation of a preferred protein’s genetic blueprint. They are integral to the analysis of particular activities, protein interplays, and the creation of innovative treatments for complex health conditions that utilize difficult-to-express proteins. For example, Amgen Inc., a US-based biopharmaceutical company, cited in its 2022 annual report that Prolia (Denosumab), a recombinant human monoclonal antibody (protein), saw a 12% increase in yearly sales, bringing in $3,628 million in 2022 versus $3,248 million in 2021. This surge in demand for recombinant proteins thus drives the expansion of the difficult-to-express protein market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12602&type=smp

How Is the Difficult-to-Express Proteins Market Segmented by Several Divisions?

The difficult-to-express proteins market covered in this report is segmented –

1) By Protein: Proteases, Kinases, Membrane Proteins, Other Proteins

2) By Expression Of Difficult Proteins: Disulfide-bonded Protein Expression, Membrane Protein Expression, Toxic Protein Expression, Target Protein Insolubility

3) By Technology: Cell-free Protein Synthesis, Prokaryotic Expression Systems, Small Ubiquitin-like Modifier (SUMO) Fusion System, Gene Fusion Systems, Other Technologies

4) By Application: Drug Discovery, Protein Purification, Protein Therapeutics, Disease Diagnostics And Monitoring, Other Applications

Subsegments:

1) By Proteases: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases

2) By Kinases: Receptor Tyrosine Kinases, Serine Or Threonine Kinases, Cyclin-Dependent Kinases

3) By Membrane Proteins: G-Protein Coupled Receptors (GPCRs), Ion Channels, Transporters

4) By Other Proteins: Transcription Factors, Structural Proteins, Enzymes

What are the Emerging Market Trends Driving the Growth of the Difficult-to-Express Proteins Industry?

The emergence of inventive technologies is a significant trend gaining traction in the market for difficult-to-express proteins. Main companies in this market are concentrating on the advancement of pioneering technologies to maintain their market standing. For example, in January 2023, Evozyne, a biotechnology firm based in the US, established a groundbreaking AI model named Protein Transformer Variational AutoEncoder for the design of therapeutic proteins. This method offers a solid structure for efficiently training and deploying extensive language models for biology. The final model is a progressive approach to deep learning, opening new opportunities for the data-driven design of engineered proteins with intended functionality.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/difficult-to-express-proteins-global-market-report

Which Regions Are Driving Growth in the Difficult-to-Express Proteins Market?

North America was the largest region in the difficult-to-express proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the difficult-to-express proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12602

This Report Delivers Insight On:

1. How big is the difficult-to-express proteins market, and how is it changing globally?

2. Who are the major companies in the difficult-to-express proteins market, and how are they performing?

3. What are the key opportunities and risks in the difficult-to-express proteins market right now?

4. Which products or customer segments are growing the most in the difficult-to-express proteins market?

5. What factors are helping or slowing down the growth of the difficult-to-express proteins market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model